Valuation Valerio Therapeutics Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate Other stock markets 07:35:45 30/07/2026 BST			5-day change	1st Jan Change
0.7490 ^EUR	+2.32%		+17.79%	+417.61%

07-16	Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies	MT
07-16	Valerio Therapeutics, Abivax Sign R&D Deal for Inflammatory Diseases' Drug Candidates	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	52.01	38.52	15.64	25.42	11.55	67.46
Change	-	-25.93%	-59.41%	62.58%	-54.58%	484.18%
Enterprise Value (EV) ¹	43.74	30.57	11.19	29.61	26.93	74.72
Change	-	-30.12%	-63.41%	164.7%	-9.03%	177.44%
P/E	66.7x	-6x	-0.76x	-1.1x	-0.47x	-6.9x
PBR	1.79x	1.17x	0.7x	1.72x	-1.29x	33.2x
PEG	-	0x	-0x	0.1x	-0.07x	0.1x
Capitalization / Revenue	29.3x	9.48x	10.8x	14.1x	6.44x	26.2x
EV / Revenue	24.6x	7.53x	7.75x	16.4x	15x	29x
EV / EBITDA	-5.69x	-5.52x	-0.66x	-1.57x	-6.91x	21.7x
EV / EBIT	-5.6x	-5.48x	-0.65x	-1.55x	-1.63x	-136x
EV / FCF	-4.87x	-4.16x	-3.83x	-3.02x	4.67x	-101x
FCF Yield	-20.5%	-24.1%	-26.1%	-33.1%	21.4%	-0.99%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	0.01	-0.07	-0.185	-0.1505	-0.16	-0.02
Distribution rate	-	-	-	-	-	-
Net sales ¹	1.776	4.062	1.443	1.8	1.793	2.573
EBITDA ¹	-7.69	-5.535	-17.04	-18.92	-3.896	3.45
EBIT ¹	-7.814	-5.582	-17.11	-19.05	-16.49	-0.55
Net income ¹	1.089	-5.937	-19.56	-20.34	-23.93	-4.898
Net Debt ¹	-8.266	-7.953	-4.452	4.184	15.38	7.26
Reference price ²	0.6670	0.4200	0.1408	0.1650	0.0750	0.1380
Nbr of stocks (in thousands)	77,977	91,722	111,059	154,077	153,972	488,848
Announcement Date	23/04/21	28/04/22	29/04/23	02/05/24	09/07/25	28/04/26

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.93x	12.83x	26.95x	0.56%	1,079B
JOHNSON & JOHNSON	28.47x	6.51x	18.01x	2.02%	640B
ABBVIE INC.	33.14x	7.75x	15.92x	2.61%	465B
ROCHE HOLDING AG	20.04x	4.79x	11.87x	2.76%	353B
NOVARTIS AG	22.45x	5.8x	14.46x	2.76%	301B
ASTRAZENECA PLC	22.33x	4.59x	13.01x	1.91%	271B
NOVO NORDISK A/S	14.91x	5.52x	11.38x	3.36%	228B
AMGEN INC.	25.46x	6.65x	11.72x	2.6%	209B
GILEAD SCIENCES, INC.	-47.83x	5.73x	31.65x	2.48%	165B
Average	17.21x	6.69x	17.22x	2.34%	412.19B
Weighted average by Cap.	25.10x	8.05x	18.96x	1.93%